Outcomes of patients with peripheral T-cell lymphoma in first complete remission: data from three tertiary Asian cancer centers

Blood Cancer J. 2017 Dec 15;7(12):653. doi: 10.1038/s41408-017-0030-y.

Tiffany Tang¹, Lay Poh Khoo¹, Cindy Lim², Jun Soo Ham³, Seok Jin Kim³, Huangming Hong^{4

5}, Colin Phipps⁶, Yuh Shan Lee⁶, Miriam Tao¹, Richard Quek^{1

7}, Mohamad Farid¹, Tongyu Lin^{4

5}, Won Seog Kim^{3

8}, Soon Thye Lim^{9

10}

¹ Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore.
² Division of Clinical Trials and Epidemiological Sciences, National Cancer Centre Singapore, Singapore, Singapore.
³ Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sunkyunkwan University School of Medicine, Seoul, Korea.
⁴ Department of Medical Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, People's Republic of China.
⁵ State Key Laboratory of Oncology in Southern China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-Sen University Cancer Centre Guangzhou, Guangzhou, People's Republic of China.
⁶ Department of Hematology, Singapore General Hospital, Singapore, Singapore.
⁷ Oncology Academic Clinical Program, Duke-NUS Graduate Medical School, Singapore, Singapore.
⁸ Department of Health Sciences and Technology, SAIHST, Sunkyunkwan University, Seoul, Korea.
⁹ Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore. lim.soon.thye@singhealth.com.sg.
¹⁰ Oncology Academic Clinical Program, Duke-NUS Graduate Medical School, Singapore, Singapore. lim.soon.thye@singhealth.com.sg.

No abstract available

Publication types